Naevoid Melanoma

• Research type

  Research Study

• Full title

  Naevoid Melanoma: Prognosis between two subtypes

• IRAS ID

  253951

• Contact name

  Martin Cook

• Contact email

  m.cook@nhs.net

• Sponsor organisation

  Royal Surrey County Hospital

• Duration of Study in the UK

  2 years, 8 months, 26 days

• Research summary

  Melanomas that have been classified as naevoid melanomas comprise two types with distinct clinical, histopathological and immunohistochemical features that may also be prognostically significant (Cook et al. 2017).
  Design:
  Using pathology reports at Royal Surrey County Hospital we will collect the demographic and clinical information of
  patients with different sub-types of naevoid melanoma.
  Overall aim:
  We will collect the details of the clinical contact and will contact them to request the patient outcome data.
  To investigate whether there is a prognostic difference between two subtypes (papillomatous and maturing naevoid melanomas).

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  19/NW/0034

• Date of REC Opinion

  24 Sep 2019

• REC opinion

  Further Information Favourable Opinion